June 10, 2025

Evotec SE (EVO) Stock Analysis: Exploring the 59.77% Potential Upside for Innovative Drug Discovery

Evotec SE (EVO) is at the forefront of the drug discovery and development sector, serving as a key partner to the pharmaceutical and biotechnology industries worldwide. Headquartered in Hamburg, Germany,..

Merus N.V. (MRUS) Stock Analysis: Exploring 63.66% Potential Upside and Strong Buy Ratings

Merus N.V. (NASDAQ: MRUS), a Netherlands-based biotechnology enterprise, has been capturing investor attention with an impressive potential upside of 63.66% according to analyst forecasts. This clinical-stage immuno-oncology company, headquartered in..

GeneDx Holdings Corp. (WGS) Stock Analysis: Unveiling a Potential 31% Upside in Genomic Diagnostics

GeneDx Holdings Corp. (NASDAQ: WGS) stands out in the healthcare sector as a pioneering entity in the Diagnostics & Research industry. Based in Stamford, Connecticut, the company specializes in providing..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech Powerhouse with a 133% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE) has emerged as a noteworthy contender in the biotechnology sector, with its innovative approach to treating inflammatory and immunology disorders. Despite a challenging market environment,..

HUTCHMED (HCM) Stock Analysis: Exploring a 60% Upside in the Healthcare Sector

HUTCHMED (China) Limited (HCM) is carving out a prominent niche in the healthcare sector, focusing on pioneering therapies for cancer and immunological diseases. With a market capitalization of $2.73 billion,..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Unearthing a 23% Upside Potential in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a compelling player in the biotechnology sector, is capturing the attention of investors with its robust pipeline of peptide therapeutics and promising market performance. Headquartered..

Phreesia, Inc. (PHR) Stock Analysis: 14.81% Potential Upside Fuels Investor Interest

Phreesia, Inc. (PHR), a key player in the Health Information Services industry, is making waves in the healthcare sector with its innovative software and payment solutions. With a market capitalization..

Acadia Healthcare (ACHC) Stock Analysis: A 94.89% Potential Upside Beckons Investors

In the vast landscape of healthcare investments, Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents a compelling case for investor attention. With a market capitalization of $2.03 billion, this Franklin, Tennessee-based..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Navigating a 17% Potential Upside Amidst Operational Challenges

Brookdale Senior Living Inc. (NYSE: BKD) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within medical care facilities. With its headquarters in Brentwood, Tennessee, Brookdale..

Surgery Partners, Inc. (SGRY) Stock Analysis: Uncovering a 34% Potential Upside in Healthcare Sector

Surgery Partners, Inc. (SGRY) stands as a noteworthy contender in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood, Tennessee, this company has carved out a..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 36.66% Potential Upside

ICU Medical, Inc. (ICUI), a key player in the healthcare sector, operates in the niche industry of medical instruments and supplies. With a market capitalization of $3.35 billion, ICU Medical..

National HealthCare Corporation (NHC) Stock Analysis: Strong Revenue Growth and Reliable Dividends for Healthcare Investors

National HealthCare Corporation (NYSE: NHC) presents a compelling case for investors interested in the healthcare sector. With a robust market capitalization of $1.62 billion, NHC operates in the medical care..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Eyeing a 75% Upside with Strong Buy Ratings

Investors with a focus on biopharmaceutical innovation might find Xenon Pharmaceuticals Inc. (NASDAQ: XENE) a compelling addition to their portfolios. Specializing in neuroscience-focused therapeutics, Xenon is at the forefront of..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring a Potential 71.65% Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a promising player in the biotechnology sector, has been capturing investor attention with its innovative approach to eye care treatment. Headquartered in Irvine, California, Tarsus..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unpacking a 142% Potential Upside

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering entity in the biotechnology sector, is drawing significant attention from investors due to its impressive potential upside of 142.52%, as indicated by recent..

Mirum Pharmaceuticals (MIRM) Stock Analysis: Potential Upside of 45.8% Draws Investor Attention

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has been capturing investor interest with its robust growth prospects and strong analyst ratings. As a player in the biotechnology sector, Mirum focuses on developing..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: A 16.62% Upside Potential in CNS Drug Market

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a prominent player in the biopharmaceutical sector, is poised for growth with an enticing potential upside of 16.62%. As the company continues to innovate in..

Guardian Pharmacy Services, Inc. (GRDN): Investor Outlook Highlights a Promising 34.45% Upside Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) is capturing the attention of investors with its impressive growth trajectory and promising market opportunities. As a key player in the healthcare sector, specifically..

AtriCure, Inc. (ATRC) Stock Analysis: Unveiling a 45.96% Potential Upside in the Surgical Devices Market

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with its potential upside of 45.96%, as..

BGM Group Ltd. (BGM): Investor Outlook on Healthcare Innovator with Mixed Performance Metrics

BGM Group Ltd. (BGM), a prominent player in China’s healthcare sector, is a fascinating entity for investors interested in unique pharmaceutical and agricultural solutions. With a market capitalization of $2.43..

Search

Funds

June 10, 2025

Search

Funds

June 10, 2025

FTSE 100

Funds